CyberLiver is a late clinical stage Prescription Digital Therapeutics platform for managing and treating Advanced Liver Diseases. We are a pioneer in discovering, developing, and delivering clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement, tracking and management tools for clinicians which are cost-effective and scalable. We lead the fight against advanced liver disease with prescription digital therapies. Two of our products have completed phase 2 equivalent clinical trials, third in discovery phase. 1. AlcoChange® - for the treatment of Alcohol-Related Liver Disease (ARLD) patients 2. CirrhoCare® - for remote monitoring and treatment of decompensated cirrhosis patients For more information, visit us at www.cyberliver.com